Novo Nordisk reported DKK20.99B in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Bausch Health Companies USD 258M 1.68B Jun/2026
Bristol-Myers Squibb USD 3.32B 640M Jun/2026
Eli Lilly USD 7.1B 301M Jun/2026
GlaxoSmithKline GBP 435M 1.3B Jun/2026
Merck USD -1.34B 2.9B Jun/2026
Novartis USD 3.26B 108M Jun/2026
Novo Nordisk DKK 20.99B 5.9B Jun/2026
Novo Nordisk DKK 3.26B 45.29B Jun/2026
Pacira USD 4.65M 1.74M Jun/2026
Sanofi EUR 343M 1.27B Jun/2026
Supernus Pharmaceuticals USD -58.37M 56.08M Jun/2026